Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Acclarent Execs Move To Appeal Off-Label Conviction

Executive Summary

Attorneys for former Acclarent executives William Facteau and Patrick Fabian have filed a request that their convictions on off-label marketing charges either be set aside or that they be granted a new trial, citing other recent off-label trials and misconduct by the government.


Related Content

Acclarent Whistleblower Says Device Off-Label Marketing Too Risky
Park Prosecutions Are Expected To Continue: Here Are Some Tips
Acclarent Pays $18m To Settle False-Claims Allegations
Former Acclarent Execs Convicted Of Misdemeanors In Off-Label Case
Vascular Solutions Case (Partially) Points Way Forward For Off-Label Marketing


Related Companies